Systemic inflammation is increasingly recognized as a crucial prognostic factor in non-small cell lung cancer (NSCLC). However, comprehensive evaluations comparing multiple inflammation-based indices in surgically treated cohorts, especially across specific ti... ...

请注册登录后继续浏览